CSF3R-POLYPEPTIDE UND ANWENDUNGEN DAVON

Patent europeic · EP2046830 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2046830
Numer da la dumonda
EP07787134
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
05-07-2007
Publitgà
15-04-2009
Concedì
15-06-2011
Stritgà
31-07-2013
Motiv
Taxa annuala betg pajada
Classas IPC
C07K 14/715 (2006.01)
C12N 15/12 (2006.01)
Prioritad
EP 06116704 06.07.2006
US 832177 P 19.07.2006
Dumonda PCT
PCT/EP2007/056846 05.07.2007
Publicaziun PCT
WO2008/003763 10.01.2008
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 19-02-2014

    Stritgà, taxa betg pajada

    Published in Swissreg on 19.02.2014

  2. 24-06-2011

    Represchentant inscrit

    Representative
    Merck Serono S.A. - Geneva, IP Department, 9, chemin des Mines, 1202 Geneva

    Published in Swissreg on 24.06.2011

  3. 15-06-2011

    Concedì

    Published in Swissreg on 15.06.2011

Partidas

Inventur

YORKE-SMITH, Melanie

Guangzhou, Guangdong 510515, CN

PIGNI, Andreas

1227 Carouge

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.